This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (128) Citing Articles via Google Scholar Google Scholar Articles by Park, S.-J. Articles by Park, S.-W. Search for Related Content PubMed PubMed Citation Articles by Park, S.-J. Articles by Park, S.-W.

Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis

Comparison with bare metal stent implantation

Seung-Jung Park, MD, PHD^*,*, Young-Hak Kim, MD^*, Bong-Ki Lee, MD^*, Seung-Whan Lee, MD^*, Cheol Whan Lee, MD, PHD^*, Myeong-Ki Hong, MD, PHD^*, Jae-Joong Kim, MD, PHD^*, Gary S. Mintz, MD and Seong-Wook Park, MD, PHD^*

^* Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
Cardiovascular Research Foundation, New York, New York.

View larger version (16K): [in a new window]   Figure 1 Kaplan-Meier curves for one-year MACE-free survival in patients treated with sirolimus-eluting stents (SES group) and bare metal stents (BMS group). A statistically significant difference was observed between the two groups (p = 0.0003). MACE = major adverse cardiac events including death, myocardial infarction, and target lesion revascularization.